Grahame J. Elder

Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial

Markus P. Schlaich, M Bellet, Michael A. Weber et al. · The Lancet · 2022 · 227 citations · Full text

Medicine, Cardiology, Pharmacology +14

Revisiting KDIGO clinical practice guideline on chronic kidney disease—mineral and bone disorder: a commentary from a Kidney Disease: Improving Global Outcomes controversies conference

Markus Ketteler, Grahame J. Elder, Pieter Evenepoel et al. · Kidney International · 2015 · 144 citations

Medicine, Nephrology, Bone Metabolism +16

Effects of Cholecalciferol on Functional, Biochemical, Vascular, and Quality of Life Outcomes in Hemodialysis Patients

Nathan A. Hewitt, A. O'Connor, Denise V. O’Shaughnessy et al. · Clinical Journal of the American Society of Nephrology · 2013 · 102 citations · Full text

Medicine, Nephrology, Nutrition +16

25-Hydroxyvitamin D Deficiency and Diabetes Predict Reduced BMD in Patients With Chronic Kidney Disease

Grahame J. Elder, Kenneth Mackun · Journal of Bone and Mineral Research · 2006 · 88 citations · Full text

Medicine, Nephrology, Dialysis +12

A Randomized Trial on the Effect of Phosphate Reduction on Vascular End Points in CKD (IMPROVE-CKD)

Nigel D. Toussaint, Eugenia Pedagogos, Nicole Lioufas et al. · Journal of the American Society of Nephrology · 2020 · 88 citations · Full text

Medicine, Nephrology, Pharmacotherapy +10